Tagraxofusp in combination with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma shows encouraging preliminary efficacy with a manageable safety profile
Haematologica. 2025 Feb 1;110(2):488-492.
doi: 10.3324/haematol.2024.285380.